Addiction Clinics Market Pricey, Unproven Treatments To Desperate Patients
An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.
Search
Filter
5,841 - 5,860 of 15,464 Results
-
-
Years Ago, This Doctor Linked A Mysterious Lung Disease To Vaping
In an exclusive interview, a West Virginia physician says that back in 2015 he had a sense a patient’s illness “probably wasn't the first case ever seen nor would it be the last.” Was it a sentinel event?
-
Readers And Tweeters Take Dialysis Providers To Task: Nowhere But In The USA
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Picture Of Health
Dialysis Industry Spends Big To Protect Profits
Dialysis companies are fighting a bill in the California legislature that could disrupt their business model. Their weapons: campaign cash and a sophisticated public relations campaign.
-
KHN’s ‘What The Health?’: All About Medicare
Before “Medicare for All,” there was just Medicare, the federal program that provides insurance to 60 million Americans. This week, KHN’s Julie Rovner talks to Tricia Neuman of the Kaiser Family Foundation about how Medicare works and whom it serves. Then, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Kimberly Leonard of the Washington Examiner join Rovner to talk about some current Medicare issues being debated in Washington, D.C.
-
Feds Pave The Way To Expand Home Dialysis — But Patients Hit Roadblocks
What changes are needed to bring home dialysis to more patients — especially older adults, the fastest-growing group of patients with serious, irreversible kidney disease? We asked nephrologists, patient advocates and dialysis company officials for their thoughts.
-
Shopping Abroad For Cheaper Medication? Here’s What You Need To Know
Americans routinely skirt federal law by crossing into Canada and Mexico or tapping online pharmacies abroad to purchase prescription medications at a fraction of the price they would pay at home. Is it safe? Not necessarily. Here’s some advice.
-
Joe Camel Was Forced Out Of Ads. So Why Is Juul Allowed On TV?
For nearly 50 years, cigarette advertising has been banned from TV and radio. But the marketing of electronic cigarettes isn’t constrained by that law.
-
MDMA, Or Ecstasy, Shows Promise As A PTSD Treatment
MDMA, the psychoactive ingredient in the club drug known as molly or ecstasy, is being tested in combination with therapy as a treatment for severe trauma.
-
Watch: Trump-Pence Policy Shift Makes Birth Control Harder To Get
The Trump administration's policy shift on Title X family planning funds is likely to make birth control harder to get and more expensive for low-income women. It will also shift funds from organizations like Planned Parenthood to the Obria Group, which does not give women hormonal contraceptives or condoms in its clinics.
-
Democrats’ Different Takes On Tackling Health Care
KHN reporter Emmarie Huetteman joined Connecticut Public Radio’s Lucy Nalpathanchil on the “Where We Live” program Tuesday to talk about the variety of options that Democratic presidential candidates are proposing for voters.
-
The Collapse Of A Hospital Empire — And Towns Left In The Wreckage
Jorge A. Perez and his management company, EmpowerHMS, helped run an empire of rural hospitals. Now, in a staggering implosion, 12 of them have entered bankruptcy and eight have closed their doors, leaving hundreds of residents without jobs and their communities without lifesaving emergency medical care. So, what happened?
By Barbara Feder Ostrov and Lauren Weber -
A Brush With A Notorious Cat, My Rabies Education And The Big Bill That Followed
An encounter with a cat led to rabies shots and provided yet another illustration of how confusing, contrary and expensive the American health care system is.
-
After A Rural Hospital Closes, Delays In Emergency Care Cost Patients Dearly
The loss of the longtime hospital in Fort Scott, Kan., forces trauma patients to deal with changing services and expectations.
-
DIY Tech Gives People More Freedom In Managing Diabetes
People with diabetes say they’ve been waiting for years for better technology to manage their chronic condition. Tired of waiting, some tech-savvy, do-it-yourselfers are constructing their own devices using open-source programming instructions.
-
Despite Failed Promises, Stem Cell Advocates Again Want Taxpayers To Pony Up Billions
California’s stem cell agency, created by a $3 billion bond measure 15 years ago, is almost out of money. Its supporters plan to ask voters for even more funding next year, even though no agency-funded treatments have been approved for widespread use.
-
Health Plan’s ‘Cadillac Tax’ May Finally Be Running Out Of Gas
The tax on generous health plans — originally envisioned as a way to help pay for the ACA and change consumers’ behavior — has never been implemented, and Congress is considering repeal.
By Julie Rovner -
What The Trump Home Dialysis Plan Would Really Look Like
It takes more than an executive order to shift kidney disease patients from dialysis centers to home care. These patients show it takes discipline, skill, will and support.
-
Among Hurdles For Those With Opioid Addictions: Getting The Drug To Treat It
It can be difficult to get a prescription for buprenorphine, one of the gold standards for treating opioid use disorder. And not all pharmacies stock the drug.
-
KHN’s ‘What The Health?’: We Answer Your Questions
You asked about drug prices, the “Cadillac tax” on generous insurance plans and why Americans don’t know that most other countries also have combination public-private insurance systems. This week, Anna Edney of Bloomberg News, Alice Miranda Ollstein of Politico and Caitlin Owens of Axios join KHN’s Julie Rovner to answer those questions.